NHS NEL
Demonstration Formulary
Demonstration Formulary
Sub Chapters : 02 Cardiovascular system
- Aldosterone antagonists
- Alpha-adrenoceptor blocking drugs
- Angiotensin-converting enzyme inhibitors (ACE inhibitors)
- Angiotensin-II receptor antagonists
- Anticoagulants and protamine
- Antifibrinolytic drugs and haemostatics
- Antiplatelet drugs
- Beta-adrenoceptor blocking drugs
- Bile acid sequestrants
- Blood-related products
- Calcium-channel blockers
- Carbonic anhydrase inhibitors
- Centrally acting antihypertensive drugs
- Digoxin-specific antibody
- Drugs affecting the renin-angiotensin system and some other antihypertensive drugs
- Ezetimibe
- Fibrates
- Fibrinolytic drugs
- Heart Failure
- Heparin
- Lipid-regulating drugs
- Local sclerosants
- Loop diuretics
- Low molecular weight heparins
- Nitrates
- Nitrates, calcium-channel blockers, and potassium-channel activators
- Omega-3 fatty acid compounds
- Oral anticoagulants
- Osmotic diuretics
- Other anitanginal drugs
- Other lipid modifying agents
- Patent Ductus Arteriosus
- Peripheral vasodilators and related drugs
- Phaeochromocytoma
- Phosphodiesterase type-3 inhibitors
- Positive inotropic drugs
- Potassium-sparing diuretics and aldosterone antagonists
- Renin inhibitors
- Stable angina, acute coronary syndromes, and fibrinolysis
- Statins
- Supraventricular and ventricular arrhythmias
- Supraventricular arrhythmias
- Sympathomimetics
- Thiazides and related diuretics
- Vasodilator antihypertensive drugs
- Ventricular arrhythmias